# A Study to Assess the Safety, Tolerability, and Effects in and on the Body of Healthy Young and Elderly Male and Female Subjects of Ascending Multiple Oral Doses of ASP3652

> **NCT02243657** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Europe B.V.** · enrollment: 101 (actual)

## Conditions studied

- Healthy Subjects
- Pharmacokinetics of ASP3652
- Pharmacodynamics of ASP3652

## Interventions

- **DRUG:** ASP3652
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02243657
- **Lead sponsor:** Astellas Pharma Europe B.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2014-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02243657

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02243657, "A Study to Assess the Safety, Tolerability, and Effects in and on the Body of Healthy Young and Elderly Male and Female Subjects of Ascending Multiple Oral Doses of ASP3652". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02243657. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*